Pub Med: Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?

Thanks To Lex Pelger for the heads up Christina M Andrews 1, Wayne Hall 2, Keith Humphreys 3 4, John Marsden 5 Affiliations expand PMID: 38845381 DOI: 10.1111/add.16575 Abstract The turn of the century brought a resurgence of interest in psychedelics as a treatment for addiction and other psychiatric conditions, accompanied by extensive positive media attention and private equity investment. Government regulatory bodies in Australia, Israel, […]